End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55 TWD | -0.54% | +1.10% | -20.63% |
Mar. 20 | CHO Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | CHO Pharma, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 60K 1.85K | Sales 2023 | - | Capitalization | 14.83B 458M |
---|---|---|---|---|---|
Net income 2022 | -338M -10.43M | Net income 2023 | -306M -9.45M | EV / Sales 2022 | 402,853 x |
Net cash position 2022 | 1.03B 31.88M | Net cash position 2023 | 2.6B 80.35M | EV / Sales 2023 | - |
P/E ratio 2022 |
-74.5
x | P/E ratio 2023 |
-43.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | -0.54% | ||
1 week | +1.10% | ||
Current month | +0.92% | ||
1 month | +1.29% | ||
3 months | -10.71% | ||
6 months | -23.08% | ||
Current year | -20.63% |
Managers | Title | Age | Since |
---|---|---|---|
Tsung I Wu
CEO | Chief Executive Officer | - | - |
Chao-Long Chen
CHM | Chairman | - | 17-12-26 |
Yi Pei Chou
DFI | Director of Finance/CFO | - | 16-03-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsing Tsai
BRD | Director/Board Member | 67 | 13-05-26 |
Hsuan Ta Liu
BRD | Director/Board Member | - | 19-06-05 |
Chao-Long Chen
CHM | Chairman | - | 17-12-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 114 M€ | +4.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 55 | -0.54% | 210,059 |
24-06-06 | 55.3 | -3.32% | 456,012 |
24-06-05 | 57.2 | +5.54% | 886,936 |
24-06-04 | 54.2 | -0.37% | 245,385 |
End-of-day quote Taipei Exchange, June 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-20.63% | 364M | |
-0.12% | 92.26B | |
-3.16% | 38.11B | |
+66.67% | 26.51B | |
-13.98% | 15.75B | |
-5.40% | 13.36B | |
-11.38% | 11.65B | |
+156.85% | 9.78B | |
-49.84% | 10.12B | |
+1.87% | 8.84B |
- Stock Market
- Equities
- 6586 Stock